BackCarysil Limited Overview

Carysil Limited EBIT

Track Carysil Limited's EBIT ($1.6B) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

$428.30M
↑ 20.07% YoY

As of Jun 30, 2026

Annual EBIT (TTM)

$1.57B
↑ 35.75% YoY

Trailing 12 months ending Jun 30, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Carysil Limited (CARYSIL.NS) FAQ

The latest EBIT for CARYSIL.NS is $1.6B as of June 2026. That compares with $1.2B in the prior-year period — up 35.7% year over year. That is below the sector sector average of $2.5T. Investors often review this figure alongside Carysil Limited's historical trend and sector peers before judging valuation or financial health.

Over the past year, CARYSIL.NS's EBIT moved from $1.2B to $1.6B — a 35.7% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Carysil Limited's operating scale or balance-sheet position.

Against its sector companies, CARYSIL.NS currently prints $1.6B for EBIT, while the sector average sits near $2.5T. That is roughly 99.9% below the sector mean. Large gaps often invite a closer look at Carysil Limited's growth, margins, and balance sheet.

A EBIT figure of $1.6B for CARYSIL.NS is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $2.5T. Explore the charts below for those layers of context.

After noting CARYSIL.NS's EBIT ($1.6B), review year-over-year change from $1.2B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.